AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was $11.77B, up 18.4% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $11.77B in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.77B | +18.4% |
| FY2024 | Dec 31, 2024 | $9.94B | +10.6% |
| FY2023 | Dec 31, 2023 | $8.98B | +3.1% |
| FY2022 | Dec 31, 2022 | $8.72B | +78.9% |
| FY2021 | Dec 31, 2021 | $4.87B | +26.9% |
| FY2020 | Dec 31, 2020 | $3.84B | +92.9% |
| FY2019 | Dec 31, 2019 | $1.99B | +26.3% |
| FY2018 | Dec 31, 2018 | $1.58B | -30.1% |
| FY2017 | Dec 31, 2017 | $2.25B | -16.6% |
| FY2016 | Dec 31, 2016 | $2.70B | +35.2% |
| FY2015 | Dec 31, 2015 | $2.00B | – |
See a number that looks wrong?